Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer. [PDF]
Ohara M +19 more
europepmc +1 more source
Progesterone receptor antagonism by mifepristone impairs trophoblast stemness and promotes apoptosis through upregulation of PDCD4. [PDF]
Zhou J +8 more
europepmc +1 more source
Assessment of the Role of Neutrophil-Lymphocyte Ratio as a Prognostic Biomarker in Breast Cancer Patients: A Cross-sectional Study. [PDF]
Takada K +8 more
europepmc +1 more source
Clinical response and prognosis of estrogen receptor-positive and human epidermal growth factor receptor-negative breast cancer patients after neoadjuvant chemotherapy: a retrospective cohort study. [PDF]
Lee JA +5 more
europepmc +1 more source
The impact of washed microbiota transplantation on serum gastric function markers: pepsinogen I, pepsinogen II, and Gastrin-17. [PDF]
Song Y +8 more
europepmc +1 more source
A tumor-targeted heptamethine cyanine dye induces suppression of progesterone receptor activity to treat hormone receptor-positive breast cancer. [PDF]
Park Y, Kim SH, Kim MS, Hyun H.
europepmc +1 more source
Novel mechanisms of atrazine endocrine disruption: an integrated approach reveals progesterone and glucocorticoid receptor targeting. [PDF]
Jin C, Hao R, Ren X, Shen J.
europepmc +1 more source
Strategically important and vulnerable subjects: the HEFCE Advisory Group’s 2010-11 report [PDF]
core
Regulatory role for tumor suppressor REST on estrogen receptor (ESR1) expression and leiomyoma pathophysiology. [PDF]
Bird SG +4 more
europepmc +1 more source

